Family case of oculopharyngeal myodystrophy in Ust-Aldansky ulus of Republic of Sakha (Yakutia)
https://doi.org/10.25789/YMJ.2021.73.32
Abstract
The clinical and genetic characteristics of a family with oculopharyngeal muscular dystrophy (OPMD) were studied in order to draw up a plan for management of such patients. Considering the course of the disease, characterized by the steady development of the disease, which leads to a decrease in the quality of life, patients with OPMD need to undergo courses of symptomatic therapy in a specialized neurological department, inform the population about the modes of transmission of the disease, prenatal diagnosis and adequate available interventions, about supportive care to reduce the risk of suffocation and other complications of OPMD.
About the Authors
M. A. VarlamovaRussian Federation
Varlamova Marina A. - Researcher, neurologist
Ph.D .: 8 (914) 298 87 60
Kh. A. Kurtanov
Russian Federation
Kurtanov Khariton A. - Candidate of Medical Sciences, Chief Researcher, Head of the Department
Ph.D .: +7 (914) 106 00 30
T. K. Davydova
Russian Federation
Davydova Tatyana K. - Candidate of Medical Sciences, Leading Researcher - Leader. TsNDZ
N. I. Pavlova
Russian Federation
Pavlova N.I. - Ph.D., Leading Researcher, Laboratory of Hereditary Pathology, Department
A. S. Petrova
Russian Federation
Petrova Anna Savvichna - chief physician
References
1. Clinical-genealogical and molecular-genetic features in patients with spinocerebelly ataxy 1 type and dentatorubropallidolidis atrophy in Yakutia/ M.A.Varlamova, P.S.Nazarova, E. A. Ilyinova [et al.] // Modern problems of science and education. - 2018. - No. 6. - P. 7-9.
2. Spinocerebellar ataxia type 17: first observations in the Russian population / S.A.Klyushnikov, D.A.Prikhodko, N.Yu. Abramycheva [et al]. // Degenerative and Vascular Diseases of the Nervous System: All-Russian Scientific and Practical Conference, dedicated to the 180th anniversary of teaching neurology at the Military Medical Academy. CM. Kirov; ed. By I.V. Litvinenko. - SPb, 2016. – P. 37-39
3. A case of nocturnal frontal lobe epilepsy in a patient with spinocerebellar ataxia type 17/ M. Belluzzo, S. Musho-Ilbeh, F. Monti F. [et al.] // Seizure. -2012. - 21:805–806. doi: 10.1212/01.wnl.0000094123.09098.А0.
4. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? / R. Koide, S. Kobayashi, T. Shimohata [et al.] // Hum. Mol. Genet. – 1999. –Vol. 8. – P. 2047–2053. DOI: 10.1093/hmg/8.11.2047.
5. A patient with 41 CAG repeats in SCA17 presenting with parkinsonism and chorea / H. Park, B.S. Jeon, J.H Shin [et al.] // Parkinsonism Relat Disord. - 2016. – Vol. 22. – P. 106–107. doi: 10.1016/j.parkreldis.2015.11.011.
6. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis / L. Schols, P. Bauer, T. Schmidt [et al.] // Lancet Neurol. – 2004. –Vol. 3- P. 291–304. DOI: 10.1016/S1474-4422(04)00737-9
7. Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutation / A.C. Bruni, J. Takahashi-Fujigasaki, F. Maltecca [et al.] // Arch. Neurol. - 2004. – Vol. – P. 1314–1320. DOI: 10.1001/archneur.61.8.1314
8. CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia / H. Fujigasaki, J.J. Martin, P.P. De Deyn [et al.] // Brain. – 2001. – Vol. 124. – P. 1939-1947. DOI: 10.1093/brain/124.10.1939
9. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17) / A. Rolfs, A.H. Koeppen, I. Bauer [et al.] // Ann Neurol. – 2003. – Vol. 54. – P. 367-375. DOI: 10.1002/Ана.10676
10. Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia / C. Zuhlke, Y. Hellenbroich, A. Dalski [et al.] // Eur. J. Hum. Genet. - 2001. – Vol. – P. 160–164. DOI: 10.1038/sj.ejhg.5200617.
11. Doherty K.M. Late onset ataxia: MSA-C or SCA 17? A gene penetrance dilemma / K.M.Doherty, T.T.Warner, A.J.Lees // Mov. Disord. -2014. – Vol. 29. – P. 36-38. doi: 10.1002/mds.25770.
12. Genetic fitness and selection intensity in a population affected with high-incidence spinocerebellar ataxia type 1 / F.A. Platonov, K. Tyryshkin, D.G. Tikhonov [et al.] // Neurogenetics. - 2016. - V.17(3). - Р.179-185. doi: 10.1007/s10048-016-0481-5.
13. Huntington’s disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes / G. Stearin, H. Fujigasaki, A.S. Lebre [et al.] // Brain. – 2003. – Vol. 126. – P. 1599-1603. DOI: 10.1093/brain/awg155
14. Intergenerational instability and marked anticipation in SCA-17 / F. Maltecca, A. Filla, I. Castaldo [et al.] // Neurology. – 2003. – Vol. 61. – P. 1441–1443. DOI: 10.1212/01.wnl.0000094123.09098.А0
15. Intergenerational instability and marked anticipation in SCA-17 / F. Maltecca, A. Filla, I. Castaldo [et al.] // Neurology. – 2003. –Vol. 61. – P. 1441–1443. doi: 10.1212/01.wnl.0000094123.09098.А0.
16. Phenotypic homogeneity of the Huntington disease-like presentation in a SCA17 family / SA van de Schneider, BP. Warrenburg, TD. Hughes [et al.] // Neurology. - 2006. - Vol. 67. P. 1701–1703. DOI: 10.1212/01.wnl.0000242740.01273.00
17. SCA 17 phenotype with intermediate triplet repeat number / H. Herrema, T. Mikkelsen, A. Robin [et al.] // J. Neurol. Sci. - 2014. –Vol. 345. - P. 269–270. DOI: 10.1016/j.jns.2014.07.041
18. SCA17 homozygote showing Huntington’s disease-like phenotype / Y. Toyoshima, M. Yamada, O. Onodera [et al.] // Ann. Neurol. - 2004. – Vol. 55. – P. 281–286. doi: 10.1002/ana.10824.
19. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein / K. Nakamura, S.Y. Jeong, T. Uchihara [et al.] // Hum. Mol. Genet. - 2001. –Vol. 10. – P. 1441–1448. DOI: 10.1093/hmg/10.14.1441.
20. SCA 17 phenotype with intermediate triplet repeat number / H. Herrema, T. Mikkelsen, A. Robin [et al.] // J. Neurol. Sci. - 2014. – Vol. 345. – P. 269–270. DOI: 10.1016/j.jns.2014.07.041.
21. Severe and rapidly progressing cognitive phenotype in a SCA17-family with only marginally expanded CAG/CAA repeats in the TATA-box binding protein gene: a case report / T.T. Nielsen, S. Mardosiene, A. Lokkegaard [et al.] // BMC Neurol. - 2012. - Vol. 12. - P. 73. DOI: 10.1186/1471-2377-12-73
22. Spinocerebellar ataxia type 17 (SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients / C. Mariotti, D. Alpini, R. Fancellu [et al.] // J. Neurol. - 2007. –Vol. 254. – P. 1538–1546. DOI: 10.1007/s00415-007-0579-7
23. Spinocerebellar Ataxia Type 17 / Y. Toyoshima, O. Onodera, M. Yamada [et al.] // In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2005 Mar 29 [updated 2019 Sep 12]. - 1993-2020. PMID: 20301611.
24. The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment / I.S. Lin, R.M. Wu, G.J. Lee-Chen [et al.] // Parkinsonism Relat Disord. - 2007. –Vol. 13. – P. 246–249. DOI: 10.1016/j.parkreldis.
25. Toyoshima Y, Takahashi H. Spinocerebellar Ataxia Type 17 (SCA17). Adv Exp Med Biol. - 2018. –Vol. 1049. P. 219-231. doi: 10.1007/978-3-319-71779-1_10. PMID: 29427105.
26. Trinucleotide repeat expansion in SCA17/ TBP in white patients with Huntington’s disease-like phenotype / P. Bauer, F. Laccone, A. [et al.] // J. Med. Genet. – 2004. –Vol. 41. – P. 230–232. doi: 10.1136/jmg.2003.015602
27. Wild E.J. Huntington’s disease phenocopy syndromes / E.J. Wild, S.J. Tabrizi // Curr Opin Neurol. - 2007. – Vol. 20. – P. 681–687. DOI: 10.1097/ВТО.0b013e3282f12074
Review
For citations:
Varlamova M.A., Kurtanov Kh.A., Davydova T.K., Pavlova N.I., Petrova A.S. Family case of oculopharyngeal myodystrophy in Ust-Aldansky ulus of Republic of Sakha (Yakutia). Yakut Medical Journal. 2021;(1):123-126. https://doi.org/10.25789/YMJ.2021.73.32